IRIS
LOPETUSO, Loris Riccardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.280
AS - Asia 2.553
EU - Europa 2.146
SA - Sud America 521
AF - Africa 57
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 8
Totale 9.577
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.171
SG - Singapore 1.436
IE - Irlanda 481
RU - Federazione Russa 465
IT - Italia 455
BR - Brasile 406
CN - Cina 361
VN - Vietnam 327
SE - Svezia 274
DE - Germania 120
HK - Hong Kong 101
GB - Regno Unito 78
CA - Canada 62
AR - Argentina 51
IN - India 48
JP - Giappone 39
AT - Austria 35
NL - Olanda 34
BD - Bangladesh 32
FR - Francia 31
MX - Messico 29
ID - Indonesia 25
IQ - Iraq 24
EC - Ecuador 22
ES - Italia 22
PL - Polonia 21
FI - Finlandia 20
TR - Turchia 18
BE - Belgio 17
RO - Romania 17
TW - Taiwan 17
ZA - Sudafrica 17
CO - Colombia 16
PK - Pakistan 16
IR - Iran 14
UA - Ucraina 14
TH - Thailandia 12
AU - Australia 11
SA - Arabia Saudita 11
BG - Bulgaria 10
EG - Egitto 10
HR - Croazia 10
MY - Malesia 10
KR - Corea 9
PE - Perù 9
NP - Nepal 8
PH - Filippine 8
UZ - Uzbekistan 7
LU - Lussemburgo 6
TN - Tunisia 6
AZ - Azerbaigian 5
EU - Europa 5
CH - Svizzera 4
CL - Cile 4
DZ - Algeria 4
JM - Giamaica 4
LT - Lituania 4
PA - Panama 4
PY - Paraguay 4
RS - Serbia 4
UY - Uruguay 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BH - Bahrain 3
CR - Costa Rica 3
DK - Danimarca 3
ET - Etiopia 3
HU - Ungheria 3
MA - Marocco 3
QA - Qatar 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GR - Grecia 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
ME - Montenegro 2
NG - Nigeria 2
NO - Norvegia 2
PT - Portogallo 2
SC - Seychelles 2
TZ - Tanzania 2
AM - Armenia 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
CY - Cipro 1
GH - Ghana 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
IL - Israele 1
IM - Isola di Man 1
KH - Cambogia 1
Totale 9.569
Salva come PNG Salva come JPEG
Città #
Singapore 946
Chandler 766
San Jose 483
Dublin 481
Ashburn 362
Dallas 259
Princeton 234
Jacksonville 191
Altamura 114
Santa Clara 107
Beijing 95
Los Angeles 94
Dong Ket 93
Ho Chi Minh City 92
Hong Kong 90
Wilmington 85
Redondo Beach 66
Ann Arbor 57
Hanoi 52
Buffalo 50
Moscow 50
Rome 49
New York 46
Chieti 43
The Dalles 42
Council Bluffs 40
Nuremberg 35
Frankfurt am Main 33
São Paulo 33
Tokyo 31
Pescara 30
Falls Church 27
Munich 23
Orem 23
London 22
Montreal 22
Chicago 21
Taranto 19
Brussels 17
Norwalk 17
Teramo 16
Rio de Janeiro 14
Stockholm 14
Denver 13
Hefei 13
Atlanta 12
Pune 12
Amsterdam 11
Guangzhou 11
Xitun 11
Baghdad 10
Cluj-Napoca 10
Columbus 10
Manchester 10
Milan 10
Tongling 10
Toronto 10
Vienna 10
Boardman 9
Brasília 9
Edinburgh 9
Helsinki 9
Mexico City 9
San Francisco 9
Sofia 9
Warsaw 9
Belo Horizonte 8
Curitiba 8
Da Nang 8
Dhaka 8
Houston 8
Palermo 8
Phoenix 8
Washington 8
Calgary 7
Guayaquil 7
Johannesburg 7
Lappeenranta 7
Macerata 7
Porto Alegre 7
Tashkent 7
Zagreb 7
Ankara 6
Bari 6
Biên Hòa 6
Bologna 6
Brooklyn 6
Chennai 6
Guglionesi 6
Haiphong 6
Jakarta 6
Kuala Lumpur 6
Lima 6
Salvador 6
Seoul 6
Tehran 6
Bangkok 5
Chiang Mai 5
Florence 5
Hangzhou 5
Totale 5.843
Salva come PNG Salva come JPEG
Nome #
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): Preliminary results from a retrospective cohort study 185
Assessment of crohn’s disease activity: Magnetic resonance enterography in comparison with clinical and endoscopic evaluations 153
13C-octanoic acid breath test to study gastric emptying time 139
Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis 133
Bacillus clausii for the treatment of acute diarrhea in children: A systematic review and meta-analysis of randomized controlled trials 114
Bacillus clausii and gut homeostasis: state of the art and future perspectives 114
Gut Microbiota: A Key Modulator of Intestinal Healing in Inflammatory Bowel Disease 114
Akkermansia muciniphila: Key player in metabolic and gastrointestinal disorders 113
A transition clinic model for inflammatory bowel disease between two tertiary care centers: outcomes and predictive factors 111
Role of Helicobacter pylori infection on nutrition and metabolism 102
The use of anti-spasmodics in the treatment of irritable bowel syndrome: Focus on otilonium bromide 102
A modern multidisciplinary approach to the treatment of enterocutaneous fistulas in Crohn’s disease patients 102
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab 100
Characterization of sarcopenia in an IBD population attending an Italian gastroenterology tertiary center 97
Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma 96
Towards a disease-associated common trait of gut microbiota dysbiosis: The pivotal role of Akkermansia muciniphila 95
Specific 13C functional pathways as diagnostic targets in gastroenterology breath-tests: tricks for a correct interpretation 95
Coordinated Multi-Language Translation of A Validated Symptom Questionnaire for Carbohydrate Intolerances: A Practical Structured Procedure 94
Role of yeasts in healthy and impaired gut microbiota: The gut mycome 94
Actinobacteria: A relevant minority for the maintenance of gut homeostasis 94
Beyond the HLA Genes in Gluten-Related Disorders 94
Changes in admissions, and hospitalization outcomes of IBD patients in an Italian tertiary referral center over a 13-year period 94
Proteobacteria: A common factor in human diseases 92
Characterization of mucosal cytokine profile in ulcerative colitis patients under conventional and anti-TNF-a treatment 92
Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol-associated liver disease 90
Assessment of neurological manifestations in hospitalized patients with COVID-19 90
The gastrointestinal microbiome - Functional interference between stomach and intestine 89
Interleukin 1β Blockade Reduces Intestinal Inflammation in a Murine Model of Tumor Necrosis Factor-Independent Ulcerative Colitis 89
Gut microbiota profiling and gut-brain crosstalk in children affected by pediatric acute-onset neuropsychiatric syndrome and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections 85
Food components and dietary habits: Keys for a healthy gut microbiota composition 84
Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for ‘gut barrier protectors’ in IBD? 84
Bacteriocins and bacteriophages: Therapeutic weapons for gastrointestinal diseases? 84
Flexible colonoscopy in mice to evaluate the severity of colitis and colorectal tumors using a validated endoscopic scoring system 83
A novel model of colitis-associated cancer in SAMP1/YitFc mice with Crohn's disease-like ileitis 83
Diagnosis of Cholangiocarcinoma: The New Biological and Technological Horizons 82
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises from a First Meta-Analysis 82
Tricks for interpreting and making a good report on hydrogen and 13C breath tests 81
The gut barrier: New acquisitions and therapeutic approaches 81
Locally injected Infliximab ameliorates murine DSS colitis: Differences in serum and intestinal levels of drug between healthy and colitic mice 81
Ulcerative colitis 81
Prevalence of cervical HPV and attitude towards cervical screening in IBD patients under immunomodulatory treatment: A multidisciplinary management experience 80
Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide 80
Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis 80
Opposing functions of classic and novel IL-1 family members in gut health and disease 79
Commensal Clostridia: Leading players in the maintenance of gut homeostasis 79
Anti-TNF-α-induced psoriasiform lesions in IBD: An abnormal immune activation or a 'patchy cutaneous' immune suppression? 79
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection—single versus multiple infusions 78
Commentary to “safety, clinical response, and microbiome findings following fecal microbiota transplant in children with inflammatory bowel disease” 76
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre 76
European Crohn's and colitis organisation topical review on treatment withdrawal ['exit strategies'] in inflammatory bowel disease 76
The innate and adaptive immune system as targets for biologic therapies in inflammatory bowel disease 76
Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome? 76
Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications 76
European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients: European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Neurogastroenterology and Motility, and European Society for Paediatric Gastroenterology Hepatology and Nutrition consensus 76
Gut microbiota and inflammatory bowel disease: So far so gut! 75
Microbiota and inflammatory bowel disease: An update 75
Liver Injury, Endotoxemia, and Their Relationship to Intestinal Microbiota Composition in Alcohol-Preferring Rats 75
Can we predict the efficacy of anti-TNF-α agents? 75
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 75
Gut Virome and Inflammatory Bowel Disease 74
Role and mechanisms of action of Escherichia coli nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update 74
IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair 74
Dietary magnesium alleviates experimental murine colitis through upregulation of the transient receptor potential melastatin 6 channel 74
Gut microbiota modulation and mucosal immunity: Focus on Rifaximin 73
High dose amoxicillin-based first line regimen is equivalent to sequential therapy in the eradication of H. Pylori infection 73
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders 72
Bariatric procedures and microbiota: patient selection and outcome prediction 71
Human herpesvirus 8-associated colonic Kaposi's sarcoma during vedolizumab treatment in ulcerative colitis: A case report and review of the literature 70
Infliximab does not increase colonic cancer risk associated to murine chronic colitis 70
Gelatin tannate and tyndallized probiotics: a novel approach for treatment of diarrhea 70
The therapeutic management of gut barrier leaking: The emerging role for mucosal barrier protectors 70
The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center 70
Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review 69
Intestinal permeability in physiological and pathological conditions: Major determinants and assessment modalities 69
Direct effect of infliximab on intestinal mucosa sustains mucosal healing: Exploring new mechanisms of action 69
Coeliac disease under a microscope: Histological diagnostic features and confounding factors 69
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: Where we stand and future perspectives 68
Microbes and Alzheimer' disease: Lessons from H. Pylori and GUT microbiota 68
Prevalence of severe irritable bowel syndrome among Italian adults. A meta-analysis 67
Epidemiological evaluation of acute gastroenteritis and therapeutic approaches in Middle East Countries 67
Epidemiology of inflammatory bowel disease in the Republic of San Marino: The “EPIMICI – San Marino” study 67
Focus on Anti-Tumour Necrosis Factor (TNF)-α-Related Autoimmune Diseases 67
Considering gut microbiota disturbance in the management of Helicobacter pylori infection 66
Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study 66
The “dica” endoscopic classification for diverticular disease of the colon shows a significant interobserver agreement among community endoscopists 65
The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications 65
Microparticles produced by activated platelets carry a potent and functionally active angiogenic signal in subjects with crohn’s disease 64
Fighting the Hype for Predictors of Efficacy in Inflammatory Bowel Disease 64
Increased Faecalibacterium abundance is associated with clinical improvement in patients receiving rifaximin treatment 64
Gut microbiota during dietary restrictions: New insights in non-communicable diseases 64
How to face the advent of sars-cov-2 vaccination in ibd patients: Another task for gastroenterologists 64
Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches 64
Predicting In-Hospital Mortality in COVID-19 Older Patients with Specifically Developed Scores 64
Epithelial-specific Toll-like Receptor (TLR)5 Activation Mediates Barrier Dysfunction in Experimental Ileitis 63
Intestinal gas production and gastrointestinal symptoms: from pathogenesis to clinical implication 62
Gut microbial flora, prebiotics, and probiotics in IBD: Their current usage and utility 62
Relationship between oral microbiota and periodontal disease: A systematic review 61
Skeletal muscle-gut axis: Emerging mechanisms of sarcopenia for intestinal and extra intestinal diseases 61
Letter: prevalence and patterns of gastrointestinal symptoms in a large Western cohort of patients with COVID-19 61
Role of microbiota and innate immunity in recurrent clostridium difficile infection 61
Totale 8.186
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.955
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.955
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021112 0 0 0 0 0 0 0 0 0 0 16 96
2021/2022705 53 3 3 118 20 16 11 28 54 39 60 300
2022/20231.882 241 337 89 224 95 348 120 143 169 18 81 17
2023/2024849 53 36 47 51 36 186 235 87 14 37 13 54
2024/20251.774 158 348 191 54 36 112 82 96 305 84 163 145
2025/20264.098 257 152 583 463 382 167 699 287 564 413 131 0
Totale 10.090